Editorial
US health care: plumbing the depths of disparities
Australia's offshore refugee policy in disarray
No free expression, no health
Comment
Role for anti-PD-L1 immune checkpoint inhibitor in advanced urothelial carcinoma
Treating giant-cell arteritis: is IL-6 the cytokine to target?
Gut microbiome and necrotising enterocolitis: time for intervention?
Food, hunger, health, and climate change
Mind the gap: jumping from vaccine licensure to routine use
Gastroenterology and hepatology: a call for papers
Making the case for supervised injection services
World Report
Canada debates medically assisted dying law
Countries mull over incentives for developing antibiotics
Concern over deteriorating rights situation in Egypt
Perspectives
Emotion, error, and judgment
Jim Smith: biologist at the heart of embryonic Francis Crick Institute
Correspondence
Children in Australia's immigration centres
Risk of stent thrombosis with bioresorbable vascular scaffolds
Intraoperative radiation therapy for breast cancer
Blood shortages and donation in China
Challenges of rare diseases in China
Organ and human trafficking in Nepal
Sugary drinks tax: response from the Institute for Fiscal Studies
Articles
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study
Global and regional health effects of future food production under climate change: a modelling study